The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Exelixis Inc (NASDAQ: EXEL) closed at $37.02 up 1.01% from its previous closing price of $36.65. In other words, the price has increased by $1.01 from its previous closing price. On the day, 2.12 million shares were traded. EXEL stock price reached its highest trading level at $37.225 during the session, while it also had its lowest trading level at $36.62.
Ratios:
For a deeper understanding of Exelixis Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.43. For the most recent quarter (mrq), Quick Ratio is recorded 3.58 and its Current Ratio is at 3.63. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On January 27, 2025, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $30 to $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when Haley Patrick J. sold 10,000 shares for $38.80 per share. The transaction valued at 388,000 led to the insider holds 341,028 shares of the business.
PATRICK JOSEPH HALEY bought 10,000 shares of EXEL for $388,000 on Mar 03 ’25. On Feb 27 ’25, another insider, Smith Julie, who serves as the Director of the company, sold 54,514 shares for $38.13 each. As a result, the insider received 2,078,619 and left with 10,778 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 10361194496 and an Enterprise Value of 9465768960. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.89, and their Forward P/E ratio for the next fiscal year is 15.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.78 while its Price-to-Book (P/B) ratio in mrq is 4.65. Its current Enterprise Value per Revenue stands at 4.365 whereas that against EBITDA is 13.17.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.58, which has changed by 0.57733274 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $40.02, while it has fallen to a 52-week low of $20.14. The 50-Day Moving Average of the stock is 4.73%, while the 200-Day Moving Average is calculated to be 25.15%.
Shares Statistics:
For the past three months, EXEL has traded an average of 2.61M shares per day and 2572550 over the past ten days. A total of 281.73M shares are outstanding, with a floating share count of 271.82M. Insiders hold about 2.88% of the company’s shares, while institutions hold 90.71% stake in the company. Shares short for EXEL as of 1740700800 were 13286921 with a Short Ratio of 5.10, compared to 1738281600 on 13094977. Therefore, it implies a Short% of Shares Outstanding of 13286921 and a Short% of Float of 6.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
